Active Ingredient Semaglutide (Highly Concentrated GLP-1 Agonist) Total Pen Strength 4 mg Semaglutide per Pre-filled Pen Dose Classification Maximum Maintenance Strength Phase Primary Brand/Manufacturer Sematrinity Administration Route Subcutaneous Injection (Weekly advanced baseline) Bundle Availability 1 Box, 2 Box, 3 Box, 4 Box, 5 Box customizable options Primary Indication Chronic Anti-Obesity & Advanced Glycemic Management
Your medical provider will determine if theyre right for your health profile
What Exactly Is Tirzepatide and How Does It Work Tirzepatide is a 39-amino acid synthetic peptide classified as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
doi: 10.1111/dom.13353 53 LingvayIHansenTMacuraSMarreMNauckMAde la RosaRet al
The exclusion criteria were as follows: (i) review articles, meta-analyses, study protocols, books, letters, and others
The team randomly administered 8mg or 12mg of retatrutide to participants for eight months and tracked changes in liver fat levels